As the popularity of weight loss drugs like Ozempic continues to climb, a disturbing pattern is emerging — and it's impacting ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

As a federal crackdown on Ozempic-style copycats looms, Hims is trying a unique new strategy to lobby lawmakers.

Researchers report yet another positive finding for GLP-1s. The participants in this trial had lower BMIs than the participants in the many other trials that have shown the benefits of the GLP-1s.

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen ...

The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...

Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.

Several studies have been done on the myriad list of side effects that come from popular weight loss drugs.  A new study ...